You are not logged in so some information on this page has been withheld. To see more, please log in or sign up.
Piper Sandler
since
auto-detected in 29 stories
12 hours ago
Biogen could see lower royalties for Ocrevus after its patent expires , but it has developed other medicines that will support its growth, per Piper Sandler.
4 days ago
Nike shares are still not cheap after 30% drawdown this year, says Piper Sandler ○
Nike could struggle with sales as the athleisure market becomes more crowded and demand for sports-focused loungewear moves past its peak, per Piper Sandler.
9 days ago
Avoid these stocks in the second quarter, says Piper Sandler ○
These stocks are underperformers in their respective sectors
30 days ago
Bill Ackman wants a little Berkshire of his own. Piper Sandler says there's a 'secret sauce' ⊖
found
Piper Sandler believes Ackman's ambition will depend largely on his ability to keep insurance risk low while letting investment returns do the heavy lifting.
70 days ago
Buy the dip: Microsoft is the best 'pure play' on AI adoption, says Piper Sandler ⊕⊕
The investment firm named shares a top pick following the stock’s big post-earnings fall last week.
3 months ago
Here's an unusual AI play for 2026: Glasses ⊕
Eyewear stock Warby Parker has room to run and offers exposure to the AI trade, according to Piper Sandler. The firm will roll out its AI glasses next year.
4 months ago
This health tech stock is a buy and can surge nearly 50% from here, says Piper Sandler ⊕
Piper Sandler's revised price target sees shares of Oscar Health soaring 49%.
5 months ago
Buy this streaming platform after strong earnings, Piper Sandler says ○
The investment firm upgraded the streaming platform to overweight from neutral.
6 months ago
This regional bank is a buy ahead of earnings next week, says Piper Sandler ○
Piper Sandler pointed to PNC's lackluster performance this year as a catalyst for investors.
Prediction markets for NFL and other events are already a $200 million business for Robinhood, says Piper Sandler ○
The investment firm, which has an overweight rating on Robinhood, raised its price target on the stock.